Atlas Trials

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study

Clinical trial NCT03769844 · COMPLETED

Trial details

NCT number
NCT03769844
Sponsor
Nationwide Children's Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pediatric Sepsis-induced MODS
Start date
2018-12-05
Primary completion
2023-12-05
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.